PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
Phospho-HDAC3 (Ser424) Antibody
#3815 · $362
100
Citing papers
10.9k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Immune cells in cancer
10
MicroRNA in disease regulation
8
RNA modifications and cancer
6
Epigenetics and DNA Methylation
6
Immune Response and Inflammation
6
Neuroinflammation and Neurodegeneration Mechanisms
6
Cancer Cells and Metastasis
6
Cancer-related Molecular Pathways
5
Papers citing this product
1
Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells
Stem Cells
·
2008
·
678 cit.
·
DOI
2
Changes of Adiponectin Oligomer Composition by Moderate Weight Reduction
Diabetes
·
2005
·
272 cit.
·
DOI
3
The Major Glycoprotein Allergen from <i>Arachis hypogaea</i>, Ara h 1, Is a Ligand of Dendritic Cell-Specific ICAM-Grabbing Nonintegrin and Acts as a Th2 Adjuvant In Vitro
The Journal of Immunology
·
2006
·
266 cit.
·
DOI
4
Reconsolidation and Extinction Are Dissociable and Mutually Exclusive Processes: Behavioral and Molecular Evidence
Journal of Neuroscience
·
2014
·
251 cit.
·
DOI
5
Cutting Edge: Involvement of the Type I IFN Production and Signaling Pathway in Lipopolysaccharide-Induced IL-10 Production
The Journal of Immunology
·
2007
·
228 cit.
·
DOI
6
Neutrophil extracellular trap induced by HMGB1 exacerbates damages in the ischemic brain
Acta Neuropathologica Communications
·
2019
·
223 cit.
·
DOI
7
IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential
Scientific Reports
·
2018
·
201 cit.
·
DOI
8
METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial–mesenchymal transition of renal tubular cells in diabetic kidney disease
Cell Death and Disease
·
2021
·
187 cit.
·
DOI
9
Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-
Journal of Clinical Investigation
·
2006
·
176 cit.
·
DOI
10
Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood–spinal cord barrier after spinal cord injury
Brain
·
2012
·
173 cit.
·
DOI
Show 90 more papers
Feedback